Australia’s medicines regulator has confirmed the death of a 48-year-old woman from NSW’s Central Coast was likely linked to the AstraZeneca vaccine.
The Therapeutic Goods Administration released a statement late on Friday evening that the woman was “admitted to hospital with an extensive thromboembolic event and thrombocytopenia (TTS) four days after receiving the AstraZeneca COVID-19 vaccine”.
“Sadly, this person died in hospital and we extend our sincerest condolences to her family,” the statement said.
The case is the first death in Australia likely linked to the vaccine and the third case of serious blood clots after receiving the vaccine.
Australia’s regulators changed their advice about giving the AstraZeneca vaccine to people aged…